Product Images Rocuronium Bromide
View Photos of Packaging, Labels & Appearance
- Structural Formula - rocuronium bromide injection 1
- rocuronium bromide injection 10
- rocuronium bromide injection 11
- rocuronium bromide injection 12
- figure 1 - rocuronium bromide injection 2
- figure 2 - rocuronium bromide injection 3
- figure 3 - rocuronium bromide injection 4
- 5 mL vial label - rocuronium bromide injection 5
- 10 mL Vial Label - rocuronium bromide injection 6
- rocuronium bromide injection 7
- rocuronium bromide injection 8
- rocuronium bromide injection 9
Product Label Images
The following 12 images provide visual information about the product associated with Rocuronium Bromide NDC 39822-4200 by Xgen Pharmaceuticals Djb, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
rocuronium bromide injection 10

This is a description for Rocuronium Bromide Injection, a medication manufactured by Xeen Pharmaceuticals for intravenous use. Each milliliter of the medication contains 10mg and comes in a 10mL multi-dose vial. The medication is labeled as a paralyzing agent and should only be used under the supervision of healthcare professionals. The text also includes some identification numbers and manufacturing information.*
rocuronium bromide injection 12

Rocuronium Bromide Injection is a medication that is administered intravenously. It is available in a concentration of 100 mg/tomL (10 mg/mL) for use.*
rocuronium bromide injection 8

XGen® Pharmaceuticals DJB is a brand name. No additional information is available from the given text.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.